Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Strategic Analysis of Global Pharmaceutical Market Size Projected to Reach USD 2,067.35 Million by 2028, Predicts Facts & Factors.

This image opens in the lightbox

News provided by

FnF Research

23 May, 2023, 15:15 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, May 23, 2023 /PRNewswire/ -- As per Facts and Factors study, the global pharmaceutical market size was worth around USD 1,482.4 million in 2021 and is estimated to grow to about USD 2,067.35 million by 2028, with a compound annual growth rate (CAGR) of approximately 5.70% over the forecast period.

Report Link with All Related Graphs & Charts: https://www.fnfresearch.com/pharmaceutical-market

Pharmaceutical Market: Overview

The pharmaceuticals market comprises businesses (organizations, sole proprietorships, and partnerships) that develop drugs used to treat illnesses and sell those drugs and associated services. Pharmaceuticals can refer to any medication used to treat diseases or for medical purposes. Businesses that manufacture medicines and biologics are a part of this sector. Pharmaceutical medications and biologics are the two market segments for pharmaceuticals. Drugs are available from pharmaceutical companies for individualized, personalized therapy of many disorders. Precision medicine, another name for customized treatment, strives to deliver medical care by the patient's unique traits and genetic makeup. Precision therapies are used more frequently as businesses abandon the one-size-fits-all approach to treating common medical ailments. Over the projection period, an increase in chronic diseases, including diabetes and cancer, is anticipated to fuel the expansion of the pharmaceutical sector.

Additionally, a rise in older adults susceptible to severe diseases will spur market expansion throughout the projection period. Reduced demand for prescription medicine, Growing competition from generic pharmaceuticals, Pharmaceutical fraud, etc., are some of the restraints in the pharmaceutical sector. Low returns on investment in the pharmaceuticals sector due to price controls, cost-containing programs, and mandated cost savings will further impede corporate growth over the projection period.

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.fnfresearch.com/sample/pharmaceutical-market

Key Insights:

  • As per the analysis shared by our research analyst, pharmaceuticals market value to grow at a CAGR of 5.70% over the forecast period.
  • In terms of revenue, the pharmaceutical market size was valued at around USD 1482.4 million in 2021 and is projected to reach USD 2067.35 million by 2028.
  • The increasing number of older adults, the growing use of personalized medicine, and coupled with rising in chronic disease across the globe are the major factors driving the market's growth.
  • By Drug Type Analysis, Drugs dominated the market in 2021
  • By Application analysis, medications for metabolic diseases dominated the sector in 2021
  • North America dominated the pharmaceutical market in 2021.

Facts and Factors published the latest report titled "Pharmaceutical Market Size, Share, Growth Analysis Report By API Type (Synthetic API, Biotech API, Monoclonal Antibodies, Cytokines, Vaccines, Blood Factors, Hormones & Growth Factors, Fusion Proteins, and Therapeutic Enzymes), By Drug (Prescription Drugs and OTC Drugs), By Customer Base (Generic Drugs and Branded Drugs), Application (Oncology, Ophthalmology, Cardiovascular Disease, Gastrointestinal Disorders, Diabetes, Endocrinology, Central Nervous System & Neurological Disorders, Nephrology, and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028" into their research database.

Industry Dynamics:

Global Pharmaceutical Market: Growth Drivers

  • Technological Advances are helping the market grow.

Challenges create opportunities, and this statement is valid for the pharmaceutical sector, which is currently dealing with the COVID-19 pandemic's effects and adapting to new conditions. Teams' efficacy has risen in many businesses due to high-tech implementations and R&D expenditures. With the help of cloud computing, machine learning, artificial intelligence, and other digital investments, life science organizations worldwide seek to improve the manufacturing cycle. Benefits include finding the best pharmaceuticals for particular ailments, conducting drug design trials on a budget, deciding when to start and stop medical treatments, collecting health data more effectively, and many other advantages.

Global Pharmaceutical Market: Restraints

  • High manufacturing cost of biologics hamper the market growth.

The settings under which biological therapies are produced and handled significantly impact their sensitivity and dependability. Quality control is crucial in creating these medications because they tend to congregate during the production and purifying. Variations in the final protein can emerge from even little changes in the synthesis process, which could have disastrous consequences. Biologics are made by biopharmaceutical businesses, which must invest additional time and money. Producing biologics involves expensive research and development costs, and the testing and manufacturing procedures are intricate. A novel biologic drug underwent eight stages of development. Only around one in every 5,000 new drugs that go through this expensive process succeed.

Directly Purchase a Copy of the Report @ https://www.fnfresearch.com/buynow/su/pharmaceutical-market

Pharmaceutical Market: Opportunities

  • Development of personalized medicine to enhance opportunities for the market.

Drugs are available from pharmaceutical companies for individualized, personalized therapy of many disorders. Precision medicine, another name for customized treatment, strives to deliver medical care by the patient's unique traits and genetic makeup. Precision therapies are used more frequently as businesses abandon the one-size-fits-all approach to treating common medical ailments. Major corporations are investing in creating tailored medications, including GSK, Teva Pharmaceuticals, and AstraZeneca.

Pharmaceutical Market: Challenges

  • Increasing consumer demands and challenges in maintaining brand health hinder the market growth.

Customers are paying close attention to pharmaceutical firms so brand management may be more crucial than usual for the remainder of the year. At the same time, customers have higher expectations for the pharmaceutical sector, and it is more typical for them to thoroughly analyze the financial value of medicine and compare prices before making a purchase. As supply chains continue hampered by COVID-19, pharmaceutical businesses must manage rising customer expectations and be ready to address brand crises all year.

Global Pharmaceutical Market: Segmentation

  • The pharmaceutical market is segregated based on API type analysis, drug type analysis, customer base type analysis, and application analysis.

The market is divided into prescription and OTC drugs based on drug type analysis. The OTC medicines segment is anticipated to increase at the fastest rate. Compared to prescribed medications, the drugs are offered directly to the customer without needing a prescription from the healthcare professional, which is credited with the segment growth.

Based on application analysis, the market is divided into oncology, ophthalmology, cardiovascular disease, gastrointestinal disorders, diabetes, endocrinology, central nervous system & neurological disorders, nephrology, and others. The pharmaceutical pharmaceuticals market's largest category was the market for medications for metabolic diseases. The dermatology drugs segment is anticipated to develop fastest in the pharmaceutical drugs market, which is categorized by medication type.

Get More Insight before Buying@: https://www.fnfresearch.com/inquiry/pharmaceutical-market

List of Key Players in Pharmaceutical Market:

  • AbbVie Inc.
  • Aurobindo Pharma
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Company
  • Lupin Pharmaceuticals Inc.
  • Abbott Laboratories
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Albemarle Corporation
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Merck & Co. Inc.
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • Sanofi
  • AstraZeneca
  • Baxter

Key questions answered in this report:

  • What are the growth rate forecast and market size for Pharmaceutical Market?
  • What are the key driving factors propelling the Pharmaceutical Market forward?
  • What are the most important companies in the Pharmaceutical Market Industry?
  • What segments does the Pharmaceutical Market cover?
  • How can I receive a free copy of the Pharmaceutical Market sample report and company profiles?

Report Scope:

Report Attribute

Details

Market size value in 2021

USD 1,482.4 Million

Revenue forecast in 2028

USD 2,067.36 Million

Growth Rate

CAGR of almost 5.31 % 2022-2028

Base Year

2022

Historic Years

2016 – 2021

Forecast Years

2022-2028

Segments Covered

By API Type, Drug, Customer Base, Application, and Region

Forecast Units

Value (USD Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2023 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

AbbVie Inc., Aurobindo Pharma, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Lupin Pharmaceuticals Inc., Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd., Albemarle Corporation, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Novartis AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Pfizer Inc., Sanofi, AstraZeneca, Baxter, and Others

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail of customized purchase options to meet your exact research needs.  

https://www.fnfresearch.com/customization/pharmaceutical-market

 Free Brochure: https://www.fnfresearch.com/ask-to-analyst/pharmaceutical-market

Regional Dominance:

  • North America to lead with the highest growth.

In 2021, North America led the market. This is due to many strategic pharmaceutical alliances, particularly among the region's well-established and early-stage businesses. Additionally, the United States held the top spot worldwide for expenditure on prescription drugs per person. Additionally, most clinical trials and drug efficacy studies conducted worldwide were in the United States. Demand for blister packaging, including improved barrier protection and lighter weight packaging, has been driven by the increased demand for tamper-evident packaging.

Due to its sizable consumer base, rising healthcare costs, increasing disease incidence, and the existence of supportive regulatory frameworks, Asia Pacific is anticipated to see the highest growth of any regional market throughout the forecast period. Additionally, to provide sustainable patient care, the area has lately adopted new technology and experienced a digital revolution. Several national-level regulations encourage big data and Artificial Intelligence (AI) application in Asian nations. The State Council of China released rules to promote the growth of big data and AI in healthcare, focusing on its use in that sector. In addition, several western businesses are building new facilities in this area since it is more affordable.

Global Pharmaceutical Market is segmented as follows:

Pharmaceutical Market: By API Type Outlook (2022-2028)

  • Synthetic API
  • Biotech API
  • Monoclonal Antibodies
  • Cytokines
  • Vaccines
  • Blood Factors
  • Hormones & Growth Factors
  • Fusion Proteins
  • Therapeutic Enzymes

Pharmaceutical Market: By Drug Type Outlook (2022-2028)

  • Prescription Drugs
  • OTC Drugs

Pharmaceutical Market: By Customer Base Type Outlook (2022-2028)

  • Generic Drugs
  • Branded Drugs

Pharmaceutical Market: By Application Outlook (2022-2028)

  • Oncology
  • Ophthalmology
  • Cardiovascular Disease
  • Gastrointestinal Disorders
  • Diabetes
  • Endocrinology
  • Central Nervous System & Neurological Disorders
  • Nephrology
  • Others

Pharmaceutical Market: By Region Outlook (2022-2028)

North America

  • The U.S.
  • Canada

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Press Release: https://www.fnfresearch.com/news/global-pharmaceutical-market

Browse Other Related Research Reports from Facts and Factors

  • Wound Care Market: According to the report published by Facts & Factors, the global wound care market size in terms of market volume was valued at USD 20.6 billion in 2022 and is predicted to surpass USD 30 billion by the end of 2028. The market is expected to grow by a CAGR of 5.6% during the forecast period of 2022-2028.
  • Cochlear Implant Market: According to the report published by Facts and Factors, the global cochlear implants market size was worth around USD 1.45 billion in 2022 and is predicted to grow to around USD 2.6 billion by 2028 with a compound annual growth rate (CAGR) of roughly 6.8% between 2023 and 2028.
  • Healthcare Augmented and Virtual Reality Market: According to the report published by Facts and Factors, the global healthcare augmented and virtual reality market size was worth around USD 2.31 billion in 2022 and is predicted to grow to around USD 19.61 billion by 2028 with a compound annual growth rate (CAGR) of roughly 26.9% between 2023 and 2028.
  • Active Wound Care Market: According to the report published by Facts and Factors, the global active wound care market size was worth around USD 9.35 billion in 2022 and is predicted to grow to around USD 14.2 billion by 2028 with a compound annual growth rate (CAGR) of roughly 5.61% between 2023 and 2028.
  • Orthopedic Prosthetic Market: According to the report published by Facts & Factors, the global orthopedic prosthetic market size was worth around USD 2.3 billion in 2022 and is predicted to grow to around USD 3.4 billion by 2030 with a compound annual growth rate (CAGR) of roughly 5.31% between 2023 and 2030.

Browse through Facts and Factors's coverage of the Global Healthcare Industry

Follow Us on: LinkedIn | Twitter | Facebook

About Us

Facts and Factors is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, and company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us: 
Facts and Factors 
Tel: +1 347 690-0211 
USA/Canada Toll-Free No. +44 2032 894158 
Email: sales@fnfresearch.com 
Website: https://www.fnfresearch.com/

Logo: https://mma.prnewswire.com/media/1981423/FnF_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.